Evaluation of Predictive Pharmacokinetic Models to Optimize Infliximab Therapy in Pediatric Inflammatory Bowel Disease
{{output}}
Background: The incidence of pediatric inflammatory bowel disease (IBD) rises yearly. Infliximab, a cornerstone of treatment, often has limited efficacy owing to high pharmacokinetic variability. Therapeutic drug monitoring and m... ...
